Brian Payne serves as Executive at CEN BIOTECH INC, where they oversee executive responsibilities. Since joining the company, Brian Payne has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 2, 2021 involved receiving (via award) 1,435,000 shares valued at $0.
Brian Payne currently holds 2,209,285 shares of CEN BIOTECH INC (CENBF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Payne has been a net neutral trader of CENBF stock. They have purchased $0 and sold $0 worth of shares.
Brian Payne's most recent insider trade was on Apr 2, 2021, when they sold 1,435,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 30, 2017 | CENBF | $0 | Award | 750,000 | $N/A | Discretionary |